Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,386,773
+$1,324,091 QoQ
Shares Held
72,842
+1.8% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
3.95%
of 13F equity value
Holder Rank
#56
of 308 holders
Holding Since
Dec 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Derivatives in PRAX
reported options exposure · as of Jun 30, 2026CallValue
$6,695,800
CallShares
20,000
PutValue
$301,311
PutShares
900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. PRAX ranks #4 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
This page
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in PRAX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,311 | 900 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $24,386,773 | 72,842 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $6,695,800 | 20,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $23,062,682 | 71,581 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,518,883 | 86,581 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $5,300,000 | 100,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $1,514,263 | 28,571 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,192,920 | 242,400 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $11,645,747 | 276,950 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,510,160 | 145,502 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $174,746 | 4,225 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $124,080 | 3,000 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $10,275,035 | 168,388 | Shares | Sole | 2024-05-17 | |
| 2024-03-31 | $1,330,236 | 21,800 | Call | Sole | 2024-05-17 | |
| 2023-12-31 | $4,456,000 | 200,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,847,500 | 2,250,000 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $357,000 | 150,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $168,434 | 74,200 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $262,640 | 107,200 | Call | Sole | 2022-08-12 | |
| 2020-12-31 | $275,100 | 5,000 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||